<p>Journey Medical Corporation（納斯達克代碼：DERM - 免費報告）- B. Riley 的分析師在 11 月 13 日星期四發佈的報告中上調了 Journey Medical 的 2029 財年每股收益（EPS）預期。B. Riley 分析師 M. Mamtani 現在預計該公司將發佈每股收益 0.93 美元，高於之前的 0.85 美元預期。市場普遍預計 Journey Medical 當前全年的每股收益為（1.02 美元）。</p>
<p>其他一些研究公司也對 DERM 發表了評論。Zacks Research 在 10 月 13 日星期一的研究報告中將 Journey Medical 的股票評級從 “強烈賣出” 上調至 “持有”。Weiss Ratings 在 10 月 8 日星期三的研究報告中重申了對 Journey Medical 股票的 “賣出（d-）” 評級。Lake Street Capital 在 8 月 13 日星期三的研究報告中將 Journey Medical 的目標價從 9.00 美元上調至 13.00 美元，並給予該公司 “買入” 評級。最後，HC Wainwright 在 8 月 25 日星期一的報告中開始覆蓋 Journey Medical 的股票。他們對該股票給予了 “買入” 評級，並設定了 13.00 美元的目標價。三位分析師對該股票給予了買入評級，一位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，該公司目前的共識評級為 “持有”，平均目標價為 12.17 美元。</p>
<p>獲取 <strong>Journey Medical</strong> 的提醒：</p>
<p><strong>查看我們關於 Journey Medical 的最新股票報告</strong></p>
<h2>Journey Medical 股票下跌 2.7%</h2>
<p>Journey Medical 的股票在週五的午盤交易中下跌 0.21 美元，達到 7.48 美元。該公司 143,313 股股票成交，較其平均成交量 124,969 股有所增加。該公司的市值為 1.9683 億美元，市盈率為-21.47，貝塔值為 0.80。Journey Medical 的 52 周低點為 3.54 美元，52 周高點為 9.40 美元。該公司的 50 日簡單移動平均線為 7.63 美元，200 日簡單移動平均線為 7.32 美元。該公司的債務與股本比率為 1.11，速動比率為 0.95，流動比率為 1.27。</p>
<p>Journey Medical（納斯達克代碼：DERM - 獲取免費報告）最近在 11 月 12 日星期三發佈了季度財報。該公司報告本季度每股收益為（0.09 美元），低於分析師共識預期的（0.08 美元）0.01 美元。Journey Medical 的股本回報率為-42.71%，淨利潤率為-14.58%。該公司本季度的收入為 1763 萬美元，而分析師預期為 1885 萬美元。</p>
<h2>機構資金流入和流出</h2>
<p>機構投資者最近對該股票的持倉進行了調整。新澤西州警察和消防員退休系統在第二季度購買了 Journey Medical 的新頭寸，價值約 29,000 美元。美國銀行在第二季度將其在 Journey Medical 的股份增加了 4,707.0%。美國銀行目前擁有 4,134 股該公司的股票，價值 30,000 美元，此前在該期間內又收購了 4,048 股。Raymond James Financial Inc.在第二季度收購了 Journey Medical 的新頭寸，價值約 36,000 美元。摩根大通在第二季度購買了 Journey Medical 的新股份，價值 41,000 美元。最後，MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第二季度收購了 Journey Medical 的新股份，價值 48,000 美元。機構投資者和對沖基金持有該公司 7.25% 的股份。</p>
<h2>Journey Medical 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Journey Medical Corporation 專注於開發和商業化用於治療美國皮膚病的藥品。該公司的市場產品包括 Qbrexza，一種用於治療原發性腋下多汗症的藥用濕巾；Accutane，一種口服異維 A 酸藥物，用於治療嚴重的頑固性結節性痤瘡；以及 Amzeeq，一種用於治療中度至重度痤瘡炎性病變的米諾環素外用製劑。</p>
<h2>瞭解更多</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Journey Medical</li>
<li>零售投資者如何交易多倫多證券交易所（TSX）？</li>
<li>艾利 Lilly 與特朗普達成協議：為什麼自那以來股價上漲了 10%</li>
<li>如何投資保險公司：指南</li>
<li>我們從 AST SpaceMobile 的第三季度財報中學到了什麼</li>
<li>三隻值得購買和持有的醫療保健分紅股票</li>
<li>三隻在每個人追逐 NVIDIA 時悄然利用 AI 的股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9REVSTQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9REVSTQ"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Journey Medical 嗎？</h2>
<p>在你考慮 Journey Medical 之前，你需要聽聽這個。</p>
<p>MarketBeat 跟蹤華爾街頂級評級和表現最佳的研究分析師及其每日推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買...而 Journey Medical 並不在名單上。</p>
<p>雖然 Journey Medical 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

DERM

<p>B. Riley 分析師將 Journey Medical 的 2029 財年每股收益預期從 0.85 美元上調至 0.93 美元。該股票的共識評級為 “持有”，平均目標價為 12.17 美元。Journey Medical 的股票目前交易價格為 7.48 美元，下跌 2.7%。該公司報告第三季度每股虧損 0.09 美元，低於預期 0.01 美元。機構投資者正在調整他們在該股票上的持倉</p>

<p>Journey Medical Corporation (NASDAQ:DERM - Free Report) - Analysts at B. Riley raised their FY2029 earnings per share (EPS) estimates for Journey Medical in a report issued on Thursday, November 13th. B. Riley analyst M. Mamtani now expects that the company will post earnings of $0.93 per share for the year, up from their previous estimate of $0.85. The consensus estimate for Journey Medical's current full-year earnings is ($1.02) per share.</p>
<div class="lb-trans"><p>Journey Medical Corporation（納斯達克代碼：DERM - 免費報告）- B. Riley 的分析師在 11 月 13 日星期四發佈的報告中上調了 Journey Medical 的 2029 財年每股收益（EPS）預期。B. Riley 分析師 M. Mamtani 現在預計該公司將發佈每股收益 0.93 美元，高於之前的 0.85 美元預期。市場普遍預計 Journey Medical 當前全年的每股收益為（1.02 美元）。</p>
</div><p>A number of other research firms have also commented on DERM. Zacks Research raised shares of Journey Medical from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report on Monday, October 13th. Weiss Ratings restated a &#34;sell (d-)&#34; rating on shares of Journey Medical in a research report on Wednesday, October 8th. Lake Street Capital increased their target price on shares of Journey Medical from $9.00 to $13.00 and gave the company a &#34;buy&#34; rating in a research note on Wednesday, August 13th. Finally, HC Wainwright assumed coverage on shares of Journey Medical in a report on Monday, August 25th. They issued a &#34;buy&#34; rating and a $13.00 price target on the stock. Three analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of &#34;Hold&#34; and an average price target of $12.17.</p>
<div class="lb-trans"><p>其他一些研究公司也對 DERM 發表了評論。Zacks Research 在 10 月 13 日星期一的研究報告中將 Journey Medical 的股票評級從 “強烈賣出” 上調至 “持有”。Weiss Ratings 在 10 月 8 日星期三的研究報告中重申了對 Journey Medical 股票的 “賣出（d-）” 評級。Lake Street Capital 在 8 月 13 日星期三的研究報告中將 Journey Medical 的目標價從 9.00 美元上調至 13.00 美元，並給予該公司 “買入” 評級。最後，HC Wainwright 在 8 月 25 日星期一的報告中開始覆蓋 Journey Medical 的股票。他們對該股票給予了 “買入” 評級，並設定了 13.00 美元的目標價。三位分析師對該股票給予了買入評級，一位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，該公司目前的共識評級為 “持有”，平均目標價為 12.17 美元。</p>
</div><p>Get <strong>Journey Medical</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Journey Medical</strong> 的提醒：</p>
</div><p><strong>View Our Latest Stock Report on Journey Medical</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 Journey Medical 的最新股票報告</strong></p>
</div><h2>Journey Medical Stock Down 2.7%</h2>
<div class="lb-trans"><h2>Journey Medical 股票下跌 2.7%</h2>
</div><p>Shares of Journey Medical stock traded down $0.21 during midday trading on Friday, reaching $7.48. 143,313 shares of the company's stock traded hands, compared to its average volume of 124,969. The company has a market cap of $196.83 million, a price-to-earnings ratio of -21.47 and a beta of 0.80. Journey Medical has a 52 week low of $3.54 and a 52 week high of $9.40. The company's 50 day simple moving average is $7.63 and its 200 day simple moving average is $7.32. The company has a debt-to-equity ratio of 1.11, a quick ratio of 0.95 and a current ratio of 1.27.</p>
<div class="lb-trans"><p>Journey Medical 的股票在週五的午盤交易中下跌 0.21 美元，達到 7.48 美元。該公司 143,313 股股票成交，較其平均成交量 124,969 股有所增加。該公司的市值為 1.9683 億美元，市盈率為-21.47，貝塔值為 0.80。Journey Medical 的 52 周低點為 3.54 美元，52 周高點為 9.40 美元。該公司的 50 日簡單移動平均線為 7.63 美元，200 日簡單移動平均線為 7.32 美元。該公司的債務與股本比率為 1.11，速動比率為 0.95，流動比率為 1.27。</p>
</div><p>Journey Medical (NASDAQ:DERM - Get Free Report) last posted its quarterly earnings results on Wednesday, November 12th. The company reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of ($0.08) by ($0.01). Journey Medical had a negative return on equity of 42.71% and a negative net margin of 14.58%.The company had revenue of $17.63 million during the quarter, compared to analyst estimates of $18.85 million.</p>
<div class="lb-trans"><p>Journey Medical（納斯達克代碼：DERM - 獲取免費報告）最近在 11 月 12 日星期三發佈了季度財報。該公司報告本季度每股收益為（0.09 美元），低於分析師共識預期的（0.08 美元）0.01 美元。Journey Medical 的股本回報率為-42.71%，淨利潤率為-14.58%。該公司本季度的收入為 1763 萬美元，而分析師預期為 1885 萬美元。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><p>Institutional investors have recently made changes to their positions in the stock. Police &amp; Firemen s Retirement System of New Jersey bought a new position in Journey Medical during the second quarter worth about $29,000. Bank of America Corp DE boosted its stake in shares of Journey Medical by 4,707.0% during the 2nd quarter. Bank of America Corp DE now owns 4,134 shares of the company's stock worth $30,000 after acquiring an additional 4,048 shares during the period. Raymond James Financial Inc. acquired a new position in shares of Journey Medical during the 2nd quarter worth approximately $36,000. JPMorgan Chase &amp; Co. bought a new stake in Journey Medical in the 2nd quarter valued at $41,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in Journey Medical during the 2nd quarter valued at $48,000. Institutional investors and hedge funds own 7.25% of the company's stock.</p>
<div class="lb-trans"><p>機構投資者最近對該股票的持倉進行了調整。新澤西州警察和消防員退休系統在第二季度購買了 Journey Medical 的新頭寸，價值約 29,000 美元。美國銀行在第二季度將其在 Journey Medical 的股份增加了 4,707.0%。美國銀行目前擁有 4,134 股該公司的股票，價值 30,000 美元，此前在該期間內又收購了 4,048 股。Raymond James Financial Inc.在第二季度收購了 Journey Medical 的新頭寸，價值約 36,000 美元。摩根大通在第二季度購買了 Journey Medical 的新股份，價值 41,000 美元。最後，MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第二季度收購了 Journey Medical 的新股份，價值 48,000 美元。機構投資者和對沖基金持有該公司 7.25% 的股份。</p>
</div><h2>Journey Medical Company Profile</h2>
<div class="lb-trans"><h2>Journey Medical 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris.</p>
<div class="lb-trans"><p>Journey Medical Corporation 專注於開發和商業化用於治療美國皮膚病的藥品。該公司的市場產品包括 Qbrexza，一種用於治療原發性腋下多汗症的藥用濕巾；Accutane，一種口服異維 A 酸藥物，用於治療嚴重的頑固性結節性痤瘡；以及 Amzeeq，一種用於治療中度至重度痤瘡炎性病變的米諾環素外用製劑。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>Five stocks we like better than Journey Medical</li>
<li>How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?</li>
<li>Eli Lilly Strikes Deal With Trump: Why Shares Are Up 10% Since</li>
<li>How to Invest in Insurance Companies: A Guide</li>
<li>Here's What We Learned From AST SpaceMobile's Q3 Earnings Report</li>
<li>The Top 3 Healthcare Dividend Stocks to Buy and Hold</li>
<li>3 Stocks Quietly Leveraging AI While Everyone Chases NVIDIA</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Journey Medical</li>
<li>零售投資者如何交易多倫多證券交易所（TSX）？</li>
<li>艾利 Lilly 與特朗普達成協議：為什麼自那以來股價上漲了 10%</li>
<li>如何投資保險公司：指南</li>
<li>我們從 AST SpaceMobile 的第三季度財報中學到了什麼</li>
<li>三隻值得購買和持有的醫療保健分紅股票</li>
<li>三隻在每個人追逐 NVIDIA 時悄然利用 AI 的股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9REVSTQ" alt="" original-src="https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx?Prefix=NASDAQ&amp;Symbol=DERM"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Journey Medical Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Journey Medical 嗎？</h2>
</div><p>Before you consider Journey Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Journey Medical 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Journey Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 跟蹤華爾街頂級評級和表現最佳的研究分析師及其每日推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買...而 Journey Medical 並不在名單上。</p>
</div><p>While Journey Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Journey Medical 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

B. Riley 上調了 Journey Medical 的盈利預測